Pneumococcie


Date de publication: 2008 Catégorie: Health care providers Type: PDFPneumococcal vaccination and risk of myocardial infarction

Pneumococcal vaccination and risk of myocardial infarction

A hospital-based case-control study that included patients considered to be at risk of myocardial infarction. Health databases were used to obtain hospital diagnoses and vaccination status. Patients who had been admitted for myocardial infarction were compared to those admitted to a surgical department in the same hospital for a reason other than myocardial infarction betwen 1997 and 2003.

Auteurs: Lamontagne F et al.
Numéro de la revue: 8
Titre de la revue: Canadian Medical Association Journal
Volume de la revue: 179
Éditeur: Canadian Medical Association

Date de publication: 2007 Catégorie: Health care providers Type: PDFInvasive pneumococcal infections in Canadian children, 1998-2003 : implications for new vaccination programs

Invasive pneumococcal infections in Canadian children, 1998-2003 : implications for new vaccination programs

Describes a study which conducted active surveillance for invasive pneumococcal disease to assess the serotype and antibiotic resistance patterns in Canada prior to universal infant immunization programs.

Auteurs: Bettinger J et al.
Numéro de la revue: 2
Titre de la revue: Canadian Journal of Public Health
Volume de la revue: 98
Éditeur: Canadian Public Health Association
Pubmed: 17441533

Date de publication: 2006 Catégorie: Health care providers Type: PDFCanadian adult national immunization coverage (Adult NICS) survey 2006

Canadian adult national immunization coverage (Adult NICS) survey 2006

Provides a broad measure of coverage of six vaccinations (influenza, pneumococcal disease, hepatitis A and B, pertussis, varicella, and tetanus) among the adult Canadian population.

Auteurs collectifs: Environics Research Group
Éditeur: Environics Research Group

Date de publication: 2004 Catégorie: Health care providers Type: Lien externe Population-based impact of pneumococcal conjugate vaccine in young children

Population-based impact of pneumococcal conjugate vaccine in young children

Determines the population impact of pneumococcal conjugate vaccine on pneumococcal-related diseases.

Auteurs: Peohling K et al.
Numéro de la revue: 3
Titre de la revue: Pediatrics
Volume de la revue: 114
Éditeur: American Academy of Pediatrics
Pubmed: 15342850

Date de publication: 2003 Catégorie: Health care providers Type: Lien externe Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

Examined population-based data from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prevention to evaluate changes in the burden of invasive disease.

Auteurs: Whitney CG et al.
Numéro de la revue: 18
Titre de la revue: New England Journal of Medicine
Volume de la revue: 348
Éditeur: Massachusetts Medical Society
Pubmed: 12724479

Date de publication: Catégorie: Health care providers Type: Lien externe Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A CIRN Serious Outcomes Surveillance network study

Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A CIRN Serious Outcomes Surveillance network study

Auteurs: LeBlanc JJ et al.
Numéro de la revue: 29
Titre de la revue: Vaccine
Volume de la revue: 35
Éditeur: Elsevier